recombinant tetrahymena lipases (Cilian/University of Munster)

N/A

Report date: 2025/06/11 10:54:51

Base Information

Drug Namerecombinant tetrahymena lipases (Cilian/University of Munster)
Drug Alias NameCL-120CL-130CL-230
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionLipase stimulantsDigestion stimulants
TargetsLipase
Therapy Area/IndicationsExocrine Pancreatic Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCilian AG
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of MunsterCilian AG
Inactive CompaniesN/A
Active IndicationsExocrine Pancreatic Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A